ARTICLE | Company News
De Novo Pharmaceuticals, GeneFormatics deal
July 29, 2002 7:00 AM UTC
The companies will research small molecule inhibitors of the M10 family of matrix metalloproteinases (MMPs). Under the deal, GeneFormatics will use its proteomics technologies to identify all members...